Phenylketonuria in Iranian population: A study in institutions for mentally retarded in Isfahan

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 526, Issue 1-2, 2003, Pages 45-52

  Vallian, Sadeq ^a   Barahimi, Elham ^a,b   Moeini, Hasan ^a  

^a UNIVERSITY OF ISFAHAN   (Iran)

^b Khatam Institute of Higher Education   (Iran)

Author keywords

Iranian population; Mutation; Phenylalanine hydroxylase; Phenylketonuria; Screening

Indexed keywords

PHENYLALANINE 4 MONOOXYGENASE;

ALLELE; ARTICLE; ASSAY; DISEASE SEVERITY; DNA POLYMORPHISM; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MENTAL DEFICIENCY; MUTATION RATE; PHENOTYPE; PHENYLKETONURIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); IRANIA;

EID: 0037448028     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(03)00015-0     Document Type: Article

References (28)

1. Levy H.L. Phenylketonuria: old disease, new approach to treatment. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1811-1813.
2. C.R. Scriver, S. Kaufman, The hyperphenylalaninemia, in: C.R. Scriver, S. Kaufman, E. Eisensmith, S.L.C. Woo, B. Vogelstein, B. Childs, The Metabolic and Molecular Bases of Inherited Disease, 8th ed., McGraw Hill, NY, 2001,Chapter 27.
3. Matalon R., Rouse B. Neonatal neurological assessment of offspring in maternal phenylketonuria. J. Inherit. Metab. Dis. 21:1998;39-48.
4. Pietz J., Dunckelmann R., Rupp A., Rating D., Meinck H.M., Schmidt H., Bremer H.J. Neurological outcome in adult patients with early-treated phenylketonuria. Eur. J. Pediatr. 157:1998;824-830.
5. Villasana D., Butler I.J., Williams J.C., Roongta S.M. Neurological deterioration in adult phenylketonuria. J. Inherit. Metab. Dis. 12:1989;451-457.
6. Waisbren S.E., Chang P., Levy H.L., Shifrin H., Allred E., Azen C., de la Cruz F., Hanley W., Koch R., Malton R., Rouse B. Neonatal neurological assessment of offspring in maternal phenylketonuria. J. Inherit. Metab. Dis. 21:1998;39-48.
7. Weglage J., Ullrich K., Pietsch M., Funders B., Zass R., Koch H.G. Untreated non-phenylketonuric-hyperphenylalaninaemia: intellectual and neurological outcome. Eur. J. Pediatr. 155(Suppl 1):1996;S26-28.
8. Guthrie R., Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 32:1963;318-343.
9. Scriver C.R., Waters P.J. Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet. 15:1999;267-272.
10. DiLella A.G., Kwok S.C., Ledley F.D., Marvit J., Woo S.L. Molecular structure and polymorphic map of the human phenylalanine hydroxylase gene. Biochemistry. 25:1986;743-749.
11. C.R. Scriver, P.M. Nowacki, S. Byck, L. Prevost, PAHdb: phenylalanine hydroxylase locus database (1999) http://www.mcgill.ca/pahdb .
12. Guldberg P., Rey F., Zschocke J., Romano V., Francois B., Michiels L., Ullrich K., Hoffmann G.F., Burgard P., Schmidt H., Meli C., Riva E., Dianzani I., Ponzone A., Rey J., Guttler F. A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am. J. Hum. Genet. 63:1998;71-79.
13. Rohr F.J., Allred E.N., Turner M., Simmons J., Levy H.L. Use of the Guthrie bacterial inhibition assay to monitor blood phenylalanine for dietary treatment of phenylketonuria. Screening. 4:1996;205-211.
14. Vallian S., Chin K.V., Chang K.S. The promyelocytic leukemia protein interacts with Sp1 and inhibits Sp1-mediated transcription of the epidermal growth factor receptor (EGFR) promoter. Mol. Cell. Biol. 18:1998;7147-7156.
15. Eisensmith R.C., Goltsov A.A., Woo S.L. A simple, rapid, and highly informative PCR-based procedure for prenatal diagnosis and carrier screening of phenylketonuria. Prenat. Diagn. 14:1994;1113-1118.
16. Goltsov A.A., Eisensmith R.C., Naughton E.R., Jin L., Chakraborty R., Woo S.L. A single polymorphic STR system in the human phenylalanine hydroxylase gene permits rapid prenatal diagnosis and carrier screening for phenylketonuria. Hum. Mol. Genet. 2:1993;577-581.
17. Goltsov A.A., Eisensmith R.C., Konecki D.S., Lichter K.U., Woo S.L. Associations between mutations and a VNTR in the human phenylalanine hydroxylase gene. Am. J. Hum. Genet. 51:1992;627-636.
18. Koochmeshg J., Bagheri A., Hosseini-Mazinani S.M. Incidence of phenylketonuria in Iran estimated from consanguineous marriages. J. Inherit. Metab. Dis. 25:2002;80-81.
19. Zschoke J., Graham C.A., Carson D.J., Nevin N.C. Phenylketonuria mutation analysis in Northern Ireland: a rapid stepwise approach. Am. J. Hum. Genet. 57:1995;1311-1317.
20. Okano Y., Asada M., Kang Y., Nishi Y., Hase Y., Oura T., Isshiki G. Molecular characterization of phenylketonuria in Japanese patients. Hum. Genet. 103:1998;613-618.
21. Holmgren G., Larsson A., Palmstiena M., Alm J. The frequency of PKU and hyperphenylalaninemia in Sweden. A study in institutions for mentally retarded as well as in neonates. Clin. Genet. 10:1976;313-318.
22. Eiken H.G., Odland E. Application of natural and amplification created restriction sites for the diagnosis of PKU. Eur. J. Hum. Genet. 7:1991;259-262.
23. Fusetti F., Erlandsen H., Flatmark T., Stevens R.C. Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria. J. Biochem. 273:1988;6962-6970.
24. Okano Y., Wang T., Eisensmith R.C., Longhi R., Riva E., Giovannini M., Cerone R., Romano C., Woo S.L.C. Phenylketonuria missense mutations in the Mediterranean. Genomics. 9:1991;96-103.
25. Mortazavi Y., Chopra R., Gordon-Smith E.C., Rutherford T.R. Frequency of the G6PD nt 1311 C/T polymorphism in English and Iranian populations: relevance to studies of X chromosome inactivation. J. Med. Genet. 34:1997;1028-1029.
26. Okano Y., Eisensmith R.C., Dasovich M., Wang T., Guttler F., Woo S.L.C. A prevalent missense mutation in Northern Europe associated with hyperphenylalaninaemia. Eur. J. Pediatr. 150:1991;347-352.
27. Svensson E., Von Dbeln U., Hagenfeldt I. Polymorphic DNA haplotypes at the phenylalanine hydroxylase locus and their relation to phenotype in Swedish phenylketonuria families. Hum. Genet. 87:1991;11-17.
28. Chao H.K., Hsiao K.J., Su T.S. A silent mutation induces exon skipping in the phenylalanine hydroxylase gene in phenylketonuria. Hum. Genet. 108:2001;14-19.